S. Shi

发表

Clinical use and pharmacological properties of selective COX-2 inhibitors

S. Shi, U. Klotz, 2008, European Journal of Clinical Pharmacology.

Pharmacokinetics and comparative bioavailability of two oral formulations of tamoxifen citrate in healthy male volunteers

S. Shi, Zhongfang Li, Shunjun Xu, 2007 .

Effects of multiple oral dosing of cyclosporine on the pharmacokinetics of quercetin in rats

S. Shi, Yani Liu, Xiaomei Luo, 2016 .

Association of RAC1 Gene Polymorphisms with Primary End-Stage Renal Disease in Chinese Renal Recipients

S. Shi, Yani Liu, Xiaomei Luo, 2016, PloS one.

Safety, tolerability, pharmacokinetics and pharmacodynamics of recombinant human parathyroid hormone after single- and multiple-dose subcutaneous administration in healthy Chinese volunteers.

S. Shi, Yani Liu, Jianhong Wu, 2012, Basic & clinical pharmacology & toxicology.

Pharmacokinetics and tolerability of intravenous cefotetan disodium for injection in healthy Chinese volunteers: A randomized, open-label, single- and multiple-dose study.

S. Shi, H. Chen, Yani Liu, 2010, Clinical therapeutics.

Tolerability and Pharmacokinetics of Hydronidone, an Antifibrotic Agent for Hepatic Fibrosis, after Single and Multiple Doses in Healthy Subjects: an Open-Label, Randomized, Dose-Escalating, First-in-Human Study

S. Shi, Yani Liu, Ying Luo, 2017, European Journal of Drug Metabolism and Pharmacokinetics.

Impact of quercetin-induced changes in drug-metabolizing enzyme and transporter expression on the pharmacokinetics of cyclosporine in rats

S. Shi, Yani Liu, Xiaomei Luo, 2016, Molecular medicine reports.

TRAF3 negatively regulates platelet activation and thrombosis

S. Shi, Xun Ai, P. Xie, 2017, Scientific Reports.

Deoxynivalenol‐induced oxidative stress and Nrf2 translocation in maternal liver on gestation day 12.5 d and 18.5 d

S. Shi, Wei Yang, Zhao Peng, 2019, Toxicon : official journal of the International Society on Toxinology.

Single‐ and Multiple‐Dose Pharmacokinetics of Pirfenidone, an Antifibrotic Agent, in Healthy Chinese Volunteers

S. Shi, Jun Wu, Jianhong Wu, 2007, Journal of clinical pharmacology.

A novel, simple and reliable method for the determination of hydronidone and its metabolites M3 and M4 in human plasma and urine by HPLC-MS/MS and its application to a pharmacokinetic study in health Chinese subjects.

S. Shi, Yani Liu, Pengpeng Guo, 2022, Analytical biochemistry.

Pharmacokinetics and relative bioavailability of a novel immunosuppressant -mycophenolate mofetil in healthy Chinese volunteers

S. Shi, Y. Wan, Zhongfang Li, 2009 .

Development and Validation of an Improved LC Method for the Simultaneous Determination of Pirfenidone and Its Carboxylic Acid Metabolite in Human Plasma

S. Shi, Jianhong Wu, F. Zeng, 2009 .

Cardiovascular effects and simultaneous pharmacokinetic and pharmacodynamic modeling of cilostazol in heahthy subjects

S. Shi, Zhongfang Li, Hua-ting Chen, 2005 .

Inhibition effect of epigallocatechin-3-gallate on the pharmacokinetics of calcineurin inhibitors, tacrolimus, and cyclosporine A, in rats

S. Shi, Yani Liu, Rui Zhang, 2020, Expert opinion on drug metabolism & toxicology.

Effects of intestinal microbiota on pharmacokinetics of cyclosporine a in rats

Rui Zhang, S. Shi, Yani Liu, 2022, Frontiers in Microbiology.

Determination of 6-Thioguanosine Diphosphate and Triphosphate and Nucleoside Diphosphate Kinase Activity in Erythrocytes: Novel Targets for Thiopurine Therapy?

U. Hofmann, M. Neurath, S. Shi, 2010, Therapeutic drug monitoring.

Pharmacokinetics and bioequivalence of levofloxacin in healthy Chinese subjects

S. Shi, Hua-ting Chen, F. Zeng, 2009 .

Pharmacokinetics and bioequivalence evaluation of azathioprine in healthy Chinese volunteers

S. Shi, Zhongfang Li, Hua-ting Chen, 2006 .

Drug Interactions with Herbal Medicines

S. Shi, U. Klotz, 2012, Clinical Pharmacokinetics.

Evaluation of antioxidant and immuno-enhancing activities of Purslane polysaccharides in gastric cancer rats.

S. Shi, Lei Jiang, Yunqiao Li, 2014, International journal of biological macromolecules.

Proton pump inhibitors: an update of their clinical use and pharmacokinetics

S. Shi, U. Klotz, 2008, European Journal of Clinical Pharmacology.

Coagulopathy is associated with multiple organ damage and prognosis of COVID-19

S. Shi, Yani Liu, Wei Yang, 2021, EXCLI journal.

Pharmacokinetics, Pharmacodynamics, and Tolerability of a Generic Formulation of Exenatide: A Randomized, Open-Label, Single- and Multiple-Dose Study in Healthy Chinese Volunteers

S. Shi, X. Zhou, Y. Liu, 2012, Arzneimittelforschung/Drug Research.

Age-related changes in pharmacokinetics.

S. Shi, U. Klotz, 2011, Current drug metabolism.

Pharmacokinetic-pharmacodynamic modeling of daurisoline and dauricine in beagle dogs.

S. Shi, F. Zeng, Hui Chen, 2003, Acta pharmacologica Sinica.

S6K1 phosphorylation-dependent degradation of Mxi1 by β-Trcp ubiquitin ligase promotes Myc activation and radioresistance in lung cancer

S. Zhang, S. Shi, Junjie Chen, 2018, Theranostics.

Lack of effect of Imrecoxib, an innovative and moderate COX-2 inhibitor, on pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers

S. Shi, Yani Liu, Rui Zhang, 2019, Scientific Reports.

Attitudes and perceptions regarding antimicrobial use and resistance among medical students in Central China

S. Shi, Hong Cheng, Dongfang Wu, 2016, SpringerPlus.

Identification and association of RAC1 gene polymorphisms with mRNA and protein expression levels of Rac1 in solid organ (kidney, liver, heart) transplant recipients.

S. Shi, Yani Liu, Xiaomei Luo, 2016, Molecular medicine reports.

CDK16 Phosphorylates and Degrades p53 to Promote Radioresistance and Predicts Prognosis in Lung Cancer

S. Shi, Junjie Chen, Shuangbing Xu, 2018, Theranostics.

The clinical implications of ageing for rational drug therapy

Ulrich Klotz, S. Shi, U. Klotz, 2008, European Journal of Clinical Pharmacology.

A simple and sensitive liquid chromatographic technique for the determination of cefotetan disodium in human plasma and its application in a pharmacokinetic study

S. Shi, Yani Liu, Jiangeng Huang, 2012, Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban.

Quercetin-3-O-β-D-glucoside decreases the bioavailability of cyclosporin A through regulation of drug metabolizing enzymes, transporters and nuclear receptors in rats

S. Shi, Yani Liu, Rui Zhang, 2018, Molecular medicine reports.

Comparative bioavailability and tolerability of a single 20-mg dose of two fluoxetine hydrochloride dispersible tablet formulations in fasting, healthy Chinese male volunteers: an open-label, randomized-sequence, two-period crossover study.

S. Shi, Yani Liu, D. Zhong, 2010, Clinical therapeutics.

STAT3 rs4796793 contributes to lung cancer risk and clinical outcomes of platinum-based chemotherapy

S. Shi, San-Lan Wu, Yu Zhang, 2019, International Journal of Clinical Oncology.

Inhibitory effects of quercetin and its major metabolite quercetin-3-O-β-D-glucoside on human UDP-glucuronosyltransferase 1A isoforms by liquid chromatography-tandem mass spectrometry

S. Shi, Yani Liu, Rui Zhang, 2021, Experimental and therapeutic medicine.

Biologics: an update and challenge of their pharmacokinetics.

S. Shi, 2014, Current drug metabolism.

Pharmacokinetics and bioequivalence evaluation of omeprazole and sodium bicarbonate dry suspensions in healthy Chinese volunteers

Rui Zhang, S. Shi, Yani Liu, 2023, Scientific Reports.

Enzyme Kinetics Studies of Nucleoside Diphosphate Kinase in HumanErythrocytes and Frequency Distribution in Healthy Subjects andTransplant Recipients in Chinese Han Population

S. Shi, Yani Liu, Xiaomei Luo, 2015 .

Precise pathological classification of non-small cell lung adenocarcinoma and squamous carcinoma based on an integrated platform of targeted metabolome and lipidome

S. Shi, Shuangbing Xu, Yani Liu, 2021, Metabolomics.

Safety, tolerability, pharmacokinetics, and pharmacodynamics of recombinant human parathyroid hormone (1-34) in healthy Chinese subjects.

S. Shi, Yani Liu, Yu Zhang, 2014, Clinical therapeutics.

Interplay of Drug-Metabolizing Enzymes and Transporters in Drug Absorption and Disposition.

S. Shi, Shaojun Shi, Yunqiao Li, 2014, Current drug metabolism.

Pharmacokinetics and tolerability of intravenous cefotetan disodium for injection in healthy Chinese volunteers: A randomized, open-label, single- and multiple-dose study

S. Shi, H. Chen, Yani Liu, 2010, Clinical Therapeutics.

A simple and sensitive liquid chromatographic technique for the determination of cefotetan disodium in human plasma and its application in a pharmacokinetic study

S. Shi, Yani Liu, Jiangeng Huang, 2012, Journal of Huazhong University of Science and Technology [Medical Sciences].

A Pharmacokinetic Drug–Drug Interactions Study between Entecavir and Hydronidone, a Potential Novel Antifibrotic Small Molecule, in Healthy Male Volunteers

Rui Zhang, S. Shi, Yani Liu, 2022, Advances in Therapy.